GHRH Receptor Signaling Research Peptide
Category: Endocrine & Receptor Signaling Research
Research Focus: GHRH Receptor Pharmacology & Molecular Signaling
CJC-1295 No DAC is a synthetic research peptide investigated in laboratory models involving growth hormone-releasing hormone receptor-associated signaling systems.
Controlled studies may examine receptor binding, molecular interactions, signal-transduction mechanisms, peptide stability, and comparative receptor pharmacology.
Material Type: Research peptide/reference material
Compound: CJC-1295 No DAC
Quantity: 10mg
Application: Laboratory and analytical research
FOR LABORATORY RESEARCH USE ONLY.
NOT FOR HUMAN CONSUMPTION.
NOT FOR HUMAN OR VETERINARY USE.
NOT FOR INJECTION, INGESTION, OR ADMINISTRATION.
NOT FOR DIAGNOSTIC, THERAPEUTIC, OR CLINICAL USE.
CJC-1295 No DAC is an investigational research compound and is not represented as an FDA-approved drug, therapeutic product, compounded medication, or substitute for any approved pharmaceutical product.
References to GHRH-associated pathways identify areas of scientific investigation only and should not be interpreted as claims regarding growth, body composition, recovery, performance, anti-aging, or therapeutic outcomes.
This information does not constitute dosing or administration guidance.
Purchase and use are restricted to lawful research purposes and are subject to the applicable Core Aminos Research Terms and Conditions.